Showing results (221-230 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancerTania Crombet, Leonel Torres, Elia Neninger, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cellsKeyur Vyas, Diana L Brassard, Marc M DeLorenzo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory responseYoung-Ik Son, Ramsey M Dallal, Michael T LotzeJournal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturationFrancesca Botta, Georges J M MaestroniJournal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patientsMargherita Gigante, Maja Mandic, Amy K Wesa, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate modelCândida F Pereira, Ruurd Torensma, Konnie Hebeda, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responsesJennifer L Freeman, Frank Vari, Derek N J HartJournal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptidesBrian Kavanagh, Andrew Ko, Alan Venook, et al.Pageof 175